The independent oncological role for cytoreductive nephrectomy in metastatic renal cell carcinoma: Prognostic features in the era of targeted therapies

Comparative Survival Following Initial Cytoreductive Nephrectomy Versus Initial Targeted Therapy for Metastatic Renal Cell Carcinoma

J Urol.

Bhindi B, Habermann EB, Mason RJ, Costello BA, Pagliaro LC, Thompson RH, Leibovich BC, Boorjian SA

doi: 10.1016/j.juro.2018.03.077.

Hypogonadism

Prospective evaluation of hypogonadism in male metastatic renal cell carcinoma patients treated with targeted therapies

Acta Clin Belg.

Bastin J, Werbrouck E, Verbiest A, Punie K, Bechter O, Woei-A-Jin SF, Wolter P, Wildiers H, Lerut E, Dumez H, Decallonne B, Clement P, Vanderschueren D, Albersen M, Oyen R, Schöffski P, Beuselinck B

doi: 10.1080/17843286.2018.

Uro-Oncology

Cytoreductive Nephrectomy in Metastatic Patients with Signs or Symptoms: Implications for Renal Cell Carcinoma Guidelines

Eur Urol.

Larcher A, Fallara G, Rosiello G, Re C, Baiamonte G, Agnesi S, Cignoli D, Colandrea G, Basile G, Briganti A, Salonia A, Bertini R, Montorsi F, Capitanio U

doi: 10.1016/j.eururo.2020.05.014.

Lymph Node Dissection is Not Associated with Improved Survival among Patients Undergoing Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma: A Propensity Score Based Analysis.

J Urol.

Gershman B, Thompson RH, Moreira DM, Boorjian SA, Lohse CM, Costello BA, Cheville JC, Leibovich BC

doi: 10.1016/j.juro.2016.09.074.

Disappearance of Renal Cysts Included in Ice Ball During Cryoablation of Renal-Cell Carcinoma: A Potential Therapy for Symptomatic Renal Cysts?

J Vasc Interv Radiol.

Yodoya M, Hiraki T, Iguchi T, Fujiwara H, Matsui Y, Masaoka Y, Sakurai J, Mitsuhashi T, Gobara H, Kanazawa S

doi: 10.1016/j.jvir.2017.02.027.

Defining the Role of Intraoperative Transesophageal Echocardiography During Radical Nephrectomy With Inferior Vena Cava Tumor Thrombectomy for Renal Cell Carcinoma

Urology.

Kostibas MP, Arora V, Gorin MA, Ball MW, Pierorazio PM, Allaf ME, Nyhan D, Brady MB

doi: 10.1016/

Uro-Oncology

Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Nivolumab plus Cabozantinib Joins Immune Checkpoint Inhibition Combination Therapies for Treatment-naïve Metastatic Clear-Cell Renal Cell Carcinoma

Eur Urol

Bedke J, Albiges L, Capitanio U, Giles RH, Hora M, Lam TB, Ljungberg B, Marconi L, Klatte T, Volpe A, Abu-Ghanem Y, Dabestani S, Pello SF, Hofmann F, Kuusk T, Tahbaz R, Powles T, Bex A

doi: 10.1016/j.eururo.2020.12.005

Uro-Oncology

Impact of Time-To-Surgery and Surgical Delay on Oncologic Outcomes for Renal Cell Carcinoma

J Urol.

Shiff B, Breau RH, Patel P, Mallick R, Tanguay S, So A, Lavallée L, Moore R, Rendon R, Kapoor A, Pouliot F, Finelli A, Bhindi B, Lattouf JB, Basappa N, Wood L, Heng D, Bjarnason G, Drachenberg D

doi: 10.1097/JU.0000000000001230.

Uro-Oncology

Comparative Genomic Profiling of Refractory and Metastatic Penile and Nonpenile Cutaneous Squamous Cell Carcinoma: Implications for Selection of Systemic Therapy

J Urol.

Jacob JM, Ferry EK, Gay LM, Elvin JA, Vergilio JA, Ramkissoon S, Severson E, Necchi A, Killian JK, Ali SM, Schrock AB, Liu NW, Chung J, Miller VA, Stephens PJ, Welsh A, Corona R, Ross JS, Bratslavsky G

doi: 10.1016/j.juro.2018.09.056.

Related content

Comparative Survival Following Initial Cytoreductive Nephrectomy Versus Initial Targeted Therapy for Metastatic Renal Cell Carcinoma

Prospective evaluation of hypogonadism in male metastatic renal cell carcinoma patients treated with targeted therapies

Cytoreductive Nephrectomy in Metastatic Patients with Signs or Symptoms: Implications for Renal Cell Carcinoma Guidelines

Lymph Node Dissection is Not Associated with Improved Survival among Patients Undergoing Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma: A Propensity Score Based Analysis.

Disappearance of Renal Cysts Included in Ice Ball During Cryoablation of Renal-Cell Carcinoma: A Potential Therapy for Symptomatic Renal Cysts?

Defining the Role of Intraoperative Transesophageal Echocardiography During Radical Nephrectomy With Inferior Vena Cava Tumor Thrombectomy for Renal Cell Carcinoma

Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Nivolumab plus Cabozantinib Joins Immune Checkpoint Inhibition Combination Therapies for Treatment-naïve Metastatic Clear-Cell Renal Cell Carcinoma

Impact of Time-To-Surgery and Surgical Delay on Oncologic Outcomes for Renal Cell Carcinoma

Comparative Genomic Profiling of Refractory and Metastatic Penile and Nonpenile Cutaneous Squamous Cell Carcinoma: Implications for Selection of Systemic Therapy